BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 19665302)

  • 41. The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency)--investigation of symptomatic and presymptomatic patients.
    Morgan SH; Rudge P; Smith SJ; Bronstein AM; Kendall BE; Holly E; Young EP; Crawfurd MD; Bannister R
    Q J Med; 1990 May; 75(277):491-507. PubMed ID: 2167495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disease manifestations and X inactivation in heterozygous females with Fabry disease.
    Maier EM; Osterrieder S; Whybra C; Ries M; Gal A; Beck M; Roscher AA; Muntau AC
    Acta Paediatr Suppl; 2006 Apr; 95(451):30-8. PubMed ID: 16720462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative thermal sensory testing in patients with monomelic amyotrophy.
    Joshi D; Bhatia M; Singh S; Goyal V; Srivastava T; Shukla G; Padma MV; Behari M
    Electromyogr Clin Neurophysiol; 2005 Dec; 45(7-8):387-91. PubMed ID: 16438346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.
    Zampetti A; Gnarra M; Borsini W; Giurdanella F; Antuzzi D; Piras A; Smaldone C; Pieroni M; Cadeddu C; de Waure C; Feliciani C
    Cytokine; 2013 Mar; 61(3):933-9. PubMed ID: 23332617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Relationship between thermal threshold and population of peripheral nerve fibers].
    Hara K; Shirabe T; Funakawa I; Yasuda T; Terao A
    Rinsho Shinkeigaku; 1994 Feb; 34(2):106-13. PubMed ID: 8194261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative sensory tests before and 1(1/2) years after orthognathic surgery: a cross-sectional study.
    Baad-Hansen L; Arima T; Arendt-Nielsen L; Neumann-Jensen B; Svensson P
    J Oral Rehabil; 2010 May; 37(5):313-21. PubMed ID: 20113390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Two cases of heterozygous Fabry disease].
    Shibuya Y; Oku N; Suzuki Y; Gomi T
    Nihon Jinzo Gakkai Shi; 2006; 48(5):421-7. PubMed ID: 16913464
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A neurophysiological study of the alterations to the central and peripheral nervous systems in Friedreich's ataxia].
    Santiago-Pérez S; Pérez-Conde MC; Ugalde-Canitrot A; López-Pajares MR
    Rev Neurol; 2007 Feb 16-28; 44(4):193-7. PubMed ID: 17311207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The function of large and small nerve fibers in renal failure.
    Angus-Leppan H; Burke D
    Muscle Nerve; 1992 Mar; 15(3):288-94. PubMed ID: 1313545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative sensory testing of cold and vibration perception during compression of median nerve at the wrist.
    Tsuboya H; Tani T; Ishida K; Ushida T; Taniguchi S; Kimura J
    Muscle Nerve; 2007 Apr; 35(4):458-64. PubMed ID: 17195168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for motor axon depolarization in Fabry disease.
    Tan SV; Lee PJ; Walters RJ; Mehta A; Bostock H
    Muscle Nerve; 2005 Oct; 32(4):548-51. PubMed ID: 16003764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma chitotriosidase in male Fabry patients: a marker for monitoring lipid-laden macrophages and their correction by enzyme replacement therapy.
    Vedder AC; Cox-Brinkman J; Hollak CE; Linthorst GE; Groener JE; Helmond MT; Scheij S; Aerts JM
    Mol Genet Metab; 2006 Nov; 89(3):239-44. PubMed ID: 16765076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
    Desnick RJ; Banikazemi M
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fabry disease.
    Schiffmann R
    Pharmacol Ther; 2009 Apr; 122(1):65-77. PubMed ID: 19318041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hearing loss in Fabry disease: data from the Fabry Outcome Survey.
    Hegemann S; Hajioff D; Conti G; Beck M; Sunder-Plassmann G; Widmer U; Mehta A; Keilmann A
    Eur J Clin Invest; 2006 Sep; 36(9):654-62. PubMed ID: 16919049
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pruritus, pain, and small nerve fiber function in keloids: a controlled study.
    Lee SS; Yosipovitch G; Chan YH; Goh CL
    J Am Acad Dermatol; 2004 Dec; 51(6):1002-6. PubMed ID: 15583600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Laser evoked potentials in carpal tunnel syndrome.
    de Tommaso M; Libro G; Difruscolo O; Sardaro M; Serpino C; Calabrese R; Vecchio E; Livrea P
    Clin Neurophysiol; 2009 Feb; 120(2):353-9. PubMed ID: 19144565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An evaluation of clinical and electrophysiologic tests in nerve injury diagnosis after mandibular sagittal split osteotomy.
    Teerijoki-Oksa T; Jääskeläinen S; Forssell K; Virtanen A; Forssell H
    Int J Oral Maxillofac Surg; 2003 Feb; 32(1):15-23. PubMed ID: 12653227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative study of the cutaneous sensation of leprosy-suspected lesions using Semmes-Weinstein monofilaments and quantitative thermal testing.
    Villarroel MF; Orsini MB; Lima RC; Antunes CM
    Lepr Rev; 2007 Jun; 78(2):102-9. PubMed ID: 17824480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peripheral nerve conduction in Fabry disease.
    Sheth KJ; Swick HM
    Ann Neurol; 1980 Apr; 7(4):319-23. PubMed ID: 6246835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.